文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Ward J. Libourel
发表
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme
E. Vellenga, B. Biemond, A. A. van de Loosdrecht, 2011, British journal of haematology.